Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease

Details for Australian Patent Application No. 2006220719 (hide)

International Classifications

Event Publications

4 October 2007 PCT application entered the National Phase

PCT publication WO2006/096663 Priority application(s): WO2006/096663

13 May 2010 Amendment Made

The nature of the amendment is: Amend co-inventor Yarden, Yosef

3 June 2010 Assignment before Grant

Targeted Molecular Diagnostics, LLC The application has been assigned to Ligacept, LLC

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.